Dr. van den Brink joins City of Hope after 24 years at Memorial Sloan Kettering Cancer Center in New York City, where he most recently led its division of hematologic malignancies, according to an Aug. 29 news release.
He has also served as vice chair of the board of the Deutsche Knochenmark Stiftung, a global blood stem cell donor registration organization.
In addition to his role as president, Dr. van den Brink will also serve as chief physician executive and the Deana and Steve Campbell Chief Physician Executive Distinguished Chair.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.